– First-Ever Non-Statin Combination Medicine, Providing 38 Percent Mean LDL-C Lowering –– Esperion Aims to Set New Industry Standard by Pricing NEXLIZET for Patient Affordability and Access with Minimal to No Paperwork Requirements for Health Care Providers –– Launch Date Accelerated by One Month at Health Care Providers Request – ANN ARBOR, Mich., June 04, 2020 (GLOBE NEWSWIRE)…

The past few months we have faced unprecedented times across the globe. The recent events, including ongoing episodes of racism and violence, underscore the urgency for us to prioritize inclusion, amplify marginalized voices, and continue to shine a light on cardiovascular health issues that affect so many. Cardiovascular disease does not discriminate by race, color,…

The American Society for Preventive Cardiology (ASPC) is collaborating with INTERVENT International (INTERVENT) to provide its members and their patients free access to INTERVENT’s evidence-based, personalized, online/digital, educational resources and content. View the article

The American Society For Preventive Cardiology (ASPC) Releases Official Scientific Statement On Continuity Of Care And Outpatient Management For Patients With And At High Risk For Cardiovascular Disease During The COVID-19 Pandemic.  View the Press Release

Esperion has announced that NEXLETOL™ (bempedoic acid) is now available in pharmacies in the United States. NEXLETOL is an oral, once-daily, tablet indicated as an adjunct to diet and maximally tolerated statin for the treatment of adults with heterozygous familial hypercholesterolemia (HeFH) or established atherosclerotic cardiovascular disease (ASCVD) who require additional lowering of LDL-C. To…

March 25, 2020, Jacksonville, FL – The American Society for Preventive Cardiology (ASPC) launches the American Journal of Preventive Cardiology, one of the only journals dedicated solely to preventive cardiology in the U.S.  “Preventive cardiology has witnessed exponential growth over the past few decades in the available clinical tools and new knowledge. We are excited…

The Million Hearts® is now taking applications for its Hospitals & Health Systems Recognition Program. The Program acknowledges institutions working to systematically improve the cardiovascular health of the population and communities they serve. Institutions can apply now through April 30, 2020 and will be among the first to be considered for the Hospitals & Health…

Watch video highlights of the ASPC’s 2019 Congress on CVD Prevention held July 19-21, 2019 in San Antonio, TX

ASPC Board Members Dr. Seth Martin and Dr. Erin Michos and the team at Johns Hopkins in collaboration with the FH Foundation published this article on Familial Hypercholesterolemia: What It Is and Who Gets It?

Watch video highlights of the ASPC’s 2018 Congress on CVD Prevention held July 27-29, 2018 in Santa Ana Pueblo, NM. Watch Video Highlights